Skip to main content
Log in

Growth Control of C6 glioma in vivo by Nerve Growth Factor

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Treatment with nerve growth factor (NGF) causes differentiation of rat C6 glioma cells and strongly inhibits their proliferation in vitro. This suggests that induction of NGF-mediated differentiation may provide a novel therapeutic approach to growth control of glial tumors. We examined the effects of NGF treatment on the growth potential of C6 glioma, which expressed NGF receptor in vivo. C6 glioma cells (1 × 106 cells/10 μl) were transplanted into the rat striatum. After 4 days, the animals were given successive injections of 100 ng NGF into the growing tumor at every 4 days (n = 10 rats). Controls were subjected to identical procedures with vehicle which did not contain NGF (n = 10 rats). At 14 days after transplantation, we evaluated the tumor volume, proliferative cell index (PCI) based on the MIB-1 immunoreactivity and enzyme activities related to energy metabolism by enzyme histochemistry. We found that the NGF treatment markedly reduced the tumor volume of the C6 glioma (34.00 ± 8.47 mm3 to 7.22 ± 4.92 mm3, p < 0.01). NGF treatment also decreased the PCI (33.34 ± 9.57% to 3.85 ± 3.56%, p < 0.01) with a negative correlation with tumor volume (r = 0.972, p < 0.01), and the hexokinase (HK) and glucose-6-phosphate dehydrogenase (G6PDH) activities (p < 0.01 and p < 0.01, respectively) which reflect the demand for nucleic acid synthesis for proliferation through the glycolytic and pentose phosphate pathways. The present results demonstrate for the first time that inhibition of tumor cell proliferation of C6 glioma by NGF occurs in vivo, probably through the NGF-mediated differentiation of C6 glioma cells which has been observed in in vitro studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Levi-Montalcini R, Angeletti P: Nerve growth factor. Physiol Rev 48: 534–569, 1968

    Google Scholar 

  2. Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal phenochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73: 2424–2428, 1976

    Google Scholar 

  3. Unsicker K, Drisch B, Otten J, Thoenen H: Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci USA 75: 3498–3502, 1978

    Google Scholar 

  4. Doupe AJ, Landis SC, Patterson PH: Environmental influence in the development of neural crest derivatives: glucocorticoids, growth factors and chromaffin cell plasticity. J Neurosci 5: 2119–2142, 1985

    Google Scholar 

  5. Lillien LE, Claude P: Nerve growth factor is a mitogen for cultured chromaffin cells. Nature 317: 632–634, 1985

    Google Scholar 

  6. Mobley WC, Woo JE, Edwards RH, Riopelle RJ, Longo FM, Weskamp G, Otten U, Valletta JS, Johnston MV: Development regulation of nerve growth factor and its receptor in the rat caudate putamen. Neuron 3: 655–664, 1989

    Google Scholar 

  7. Cattaneo E, McKay R: Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347: 762–765, 1990

    Google Scholar 

  8. Tischler AS, Riseberg JC, Hardenbrook MA, Cherington V: Nerve growth factor is a potent inducer of proliferation and neuronal differentiation for adult rat chromaffin cells in vitro. J Neurosci 13: 1533–1542, 1993

    Google Scholar 

  9. Li Y, Holtman DM, Kromer LF, Kaplan DR, Chua-Couzens J, Clary DO, Knusel B, Mobley WC: Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 15: 2888–2905, 1995

    Google Scholar 

  10. Barbacid M: The trk family of neurotrophin receptors. J Neurobiol 25: 1386–1403, 1994

    Google Scholar 

  11. Niederhauser O, Mangold M, Schubenel R, Kusznir EA, Schmidt D, Hertel C: NGF ligand alters NGF signaling via p75NTR and TrkA. J Neurosci Res 61: 263–272, 2000

    Google Scholar 

  12. Yoon SO, Casacci-Bonnefil P, Carter B, Chao MV: Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 18: 3273–3281, 1998

    Google Scholar 

  13. Kahle P, Barker PA, Shooter EM, Hertel C: p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells. J Neurosci Res 38: 599–606, 1994

    Google Scholar 

  14. Ross GM, Shamovsky IL, Lawrance G, Solc M, Dostaler SM, Weaver DF, Riopelle RJ: Reciprocal modulation ofTrkA andp75NTRaffinity states is mediated by direct receptor interactions. Eur J Neurosci 10: 890–898, 1998

    Google Scholar 

  15. Kumar S, Huber J, Pena LA, Perez-Polo JR, Werrbach-Perez K, de Vellis J: Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. J Neurosci Res 27: 408–417, 1990

    Google Scholar 

  16. Zanellato A, Facci L, Petrelli L, Dal Toso R, Skaper SD: Characterization and growth-dependent regulation of the nerve growth factor receptor gp140trk in rat C6 glioma cells. Mol Brain Res 23: 299–309, 1994

    Google Scholar 

  17. Watanabe T, Katayama Y, Kimura S, Yoshino A: Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system. J Neuro-Oncol 41: 121–128, 1999

    Google Scholar 

  18. Tornatore C, Rabin S, Baker-Cairns B, Keir S, Mocchetti I: Engraftment of C6–2B cells into the striatum of ACI nude rats as a tool for comparison of the in vitro and in vivo phenotype of a glioma cell line. Cell Transplant 6: 317–326, 1997

    Google Scholar 

  19. Kokunai T, Iguchi H, Tamaki N: Differentiation and growth inhibition of glioma cells induced by transfer of Trk A proto-oncogene. J Neuro-Oncol 42: 23–34, 1999

    Google Scholar 

  20. Johnson EM Jr, Gorin PD, Brandeis LD, Pearson J: Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210: 916–918, 1980

    Google Scholar 

  21. Martin DP, Schmidt RE, Distefano PS, Lowry OH, Capter JG, Johnson EM Jr: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829–844, 1988

    Google Scholar 

  22. Deckwerth TL, Johnson EM: Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 123: 1207–1222, 1993

    Google Scholar 

  23. Pittman RN, Wang S, DiBenedetto AJ, Mills JC: A system for characterizing cellular and molecular events in programmed neuronal cell death. J Neurosci 13: 3669–3680, 1993

    Google Scholar 

  24. Freeman RS, Estus S, Johnson EM: Analysis of cell cyclerelated gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron 12: 343–355, 1994

    Google Scholar 

  25. Muragaki Y, Chou TT, Kaplan DR, Trojanowski JQ, Lee VM: Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J Neurosci 17: 530–542, 1997

    Google Scholar 

  26. Tajima Y, Molina RP Jr, Rorke LB, Kaplan DR, Radeke M, Feinstein SC, Lee VM, Trojanowski JQ: Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors. Acta Neuropathol 95: 325–332, 1998

    Google Scholar 

  27. Chou TT, Trojanowski JQ, Lee VM: A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma. J Biol Chem 275: 565–570, 2000

    Google Scholar 

  28. Dominguez JE, Graham JF, Cummins CJ, Loreck DJ, Galarraga J, Van der Feen J, DeLaPaz R, Smith BH: Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase levels. Metab Brain Dis 2: 17–30, 1987

    Google Scholar 

  29. Ikezaki K, Black KL, Conklin SG, Becker DP: Histochemical evaluation of energy metabolism in rat glioma. Neurol Res 14: 289–293, 1992

    Google Scholar 

  30. Lawrence GM, Trayer IP: Histochemical and immunohistochemical localization of hexokinase isoenzymes in rat kidney. Histochem J 16: 697–708, 1984

    Google Scholar 

  31. Bancroft JD: Enzyme histochemistry. In: Bancroft JD, Stevens A (eds) Theory and Practice of Histological Techniques. Churchill Livingstone, NewYork, pp 397–400, 1982

    Google Scholar 

  32. Wong-Riley MTT: Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12: 94–101, 1989

    Google Scholar 

  33. Darriet D, Der T, Collins RC: Distribution of cytochrome oxidase in rat brain: studies with diaminobenzidine histochemistry in vitro and [14C] cyanide tissue labeling in vivo. J Cereb Blood Flow Metab 6: 8–14, 1986

    Google Scholar 

  34. Mennel HD: Transplantation of tumors of the nervous system, induced by resorptive carcinogens. 1. Histological investigation of intracerebrally transplanted tumors of the central nervous system. Neurosurg Rev 1: 123–131, 1978

    Google Scholar 

  35. Hürter T, Mennel HD: Experimental brain tumors and edema in rats: 1. Histology and cytology of tumors. Acta Neuropathol 55: 105–111, 1981

    Google Scholar 

  36. Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H: NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res 285: 45–52, 1983

    Google Scholar 

  37. Hefti F, Dravid A, Hartikka J: Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 293: 305–311, 1984

    Google Scholar 

  38. Williams LR, Varon S, Peterson GF, Wictorin K, Brorklund A, Gage FH: Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83: 9231–9235, 1986

    Google Scholar 

  39. Kromer LF: Nerve growth factor treatment after brain injury prevents neuronal death. Science 235: 214–216, 1987

    Google Scholar 

  40. Gage FH, Armstrong DM, Williams LR, Varon S: Morphological response of axotomized septal neurons to nerve growth factor. J Comp Neurol 269: 147–155, 1988

    Google Scholar 

  41. Warburg O: On the origin of cancer cells. Science 123: 309–314, 1956

    Google Scholar 

  42. Bustamante E, Pedersen PL: High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA 74: 3735–3739, 1977

    Google Scholar 

  43. Pederson PL: Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 22: 190–274, 1978

    Google Scholar 

  44. Allen N: Oxidative metabolism of brain tumors. Prog Exp Tumor Res 17: 192–209, 1972

    Google Scholar 

  45. Di Chiro G, DeLaPaz RL, Brooks R, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP: Glucose utilization of cerebral gliomas measured by [18F]-fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329, 1982

    Google Scholar 

  46. Kornblith PL, Cummins CJ, Smith BH, Brooks RA, Patronas NJ, Di Chiro G: Correlation of experimental and clinical studies of metabolism by PET scanning. Prog Exp Tumor Res 27: 170–178, 1984

    Google Scholar 

  47. Lichtor T, Dorhmann GJ: Oxidative metabolism and glycolysis in benign brain tumors. J Neurosurg 67: 336–340, 1987

    Google Scholar 

  48. Floridi A, Paggi MG, Fanciulli M: Modulation of glycolysis in neuroepithelial tumors. J Neurosurg Sci 33: 55–64, 1989

    Google Scholar 

  49. Meixensberger J, Herting B, Roggendorf W, Reichmann H: Metabolic patterns in malignant gliomas. J Neuro-Oncol 24: 153–161, 1995

    Google Scholar 

  50. Lowry OH, Berger SJ, Carter JC, Chi MMY, Manchester JK, Knor J, Pusateri ME: Diversity of metabolic patterns in human brain tumors: enzymes of energy metabolism and related metabolites and cofactors. J Neurochem 41: 994–1010, 1983

    Google Scholar 

  51. Oudard S, Boitier E, Miccoli L, Rousset S, Dutrillaux B, Poupon MF: Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res 17: 1903–1911, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimura, S., Yoshino, A., Katayama, Y. et al. Growth Control of C6 glioma in vivo by Nerve Growth Factor. J Neurooncol 59, 199–205 (2002). https://doi.org/10.1023/A:1019919019497

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019919019497

Navigation